Investigating the Minimum Number of Needling Required to Optimize Trigger Point Injections Outcome

PHASE2Enrolling by invitationINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

April 20, 2021

Primary Completion Date

December 9, 2025

Study Completion Date

December 9, 2025

Conditions
Myofascial PainMyofascial Trigger Point Pain
Interventions
COMBINATION_PRODUCT

1% plain lidocaine and 0.25% plain bupivacaine

A 5- or 10-ml syringe will be filled equally with 1% plain lidocaine and 0.25% plain bupivacaine. A 1.5-inch 25-gauge needle will be attached to the syringe. The needle will be carefully inserted at the first trigger point and 2 mls of the mixed local anesthetic will be infiltrated. At that point, the needle will be carefully inserted into the trigger point based on the group assigned. Once needling is done for the first trigger point, the process will be repeated in exactly the same fashion for the remaining points.

Trial Locations (1)

85711

Banner University Medical Center Multispecialty Services Clinic, Tucson

All Listed Sponsors
lead

University of Arizona

OTHER